Oracle Corp: Form 10-K for the period ended May 31, 2023
Filed with the SEC on Jun 20, 2023 and accepted by EDGAR at Jun 20, 2023, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-05-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-06-01 to 2023-05-31 | $49.95bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2022-06-01 to 2023-05-31 | $8.62bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-06-01 to 2023-05-31 | $13.09bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-06-01 to 2023-05-31 | $3.50bn | us-gaap:InterestExpense |
| Income tax | 12 months2022-06-01 to 2023-05-31 | $623.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-06-01 to 2023-05-31 | $8.50bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-06-01 to 2023-05-31 | $3.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-06-01 to 2023-05-31 | $3.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-06-01 to 2023-05-31 | 2,766,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-06-01 to 2023-05-31 | $17.16bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-06-01 to 2023-05-31 | $8.70bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-06-01 to 2023-05-31 | $3.67bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-06-01 to 2023-05-31 | $1.30bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-05-31 | $9.77bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-05-31 | $21.00bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-05-31 | $134.38bn | us-gaap:Assets |
| Current liabilities | At period end2023-05-31 | $23.09bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2023-05-31 | $4.06bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-05-31 | $1.07bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-028914. Last ingested by Listed: Nov 2, 2026, 20:19 ET. Listed shows no prices and gives no investment advice.